Clinical Trial to Investigate the Efficacy and Safety of LN-OS-22 on Oxidative Stress and Systemic Inflammation in Overweight and Obese Population.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

March 13, 2023

Study Completion Date

March 13, 2023

Conditions

Oxidative Stress

Interventions

OTHER

LN-OS-22

2 capsules orally once a day to be taken with a glass of milk after breakfast for 56 days

OTHER

Maltodextrin

2 capsules orally once a day to be taken with a glass of milk after breakfast for 56 days

Trial Locations (3)

Ayush Nursing Home, Mumbai

Dr. Awate's Clinic, Mumbai

Metabol-Lifestyle metabolic syndrome clinic, Mumbai

All Listed Sponsors

lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY